Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 51 - 60 of 144

Selected Filters:
12 August 2022

Plan 4 Ring Toolkit: Healthcare Provider Training Considerations

This document can inform the development of training curricula for new biomedical HIV prevention products, including the dapivirine ring. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to support national planning for the introduction and scale-up of the dapivirine ring.

Normative Guidance/Policies, Service Delivery

Document
12 August 2022

Plan 4 Ring Toolkit: Facility Readiness Assessments

These two site readiness tools, for the public sector and for pharmacies, are designed to help determine site readiness to provide the dapivirine ring to end users. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to support national planning for the introduction and scale-up of the…

Normative Guidance/Policies, Service Delivery

Document
12 August 2022

Plan 4 Ring Toolkit: Service Delivery Channel Analysis Template

This template can be used by policymakers or others supporting policy development for the dapivirine ring to define an approach to ring rollout by prioritizing among different delivery channels. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to support national planning for the introduction and scale-up…

Service Delivery

Presentation
12 August 2022

Plan 4 Ring Toolkit: Rollout Scenarios Analysis Template

This tool uses existing data, including data on HIV incidence and oral PrEP use, to develop an analysis that prioritizes subnational regions (e.g., provinces, states, districts, or counties) for dapivirine ring rollout and defines several scenarios for rolling out the ring. This tool is part of the Plan 4 Ring toolkit, a suite of resources…

Normative Guidance/Policies, Service Delivery

Presentation
12 August 2022

Plan 4 Ring Toolkit: Guidelines Template

The intent of this document is to provide adaptable guidelines that align with the World Health Organization (WHO) guidance and recommendations for implementation of the dapivirine ring. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to support national planning for the introduction and scale-up of the…

Normative Guidance/Policies

Document
12 August 2022

Plan 4 Ring Toolkit: Situation Analysis Template

This template can be used to conduct a situational analysis to help plan for rollout of the dapivirine ring. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to support national planning for the introduction and scale-up of the dapivirine ring.

Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery, Supply Chain Management

Presentation
12 August 2022

Plan 4 Ring Toolkit: Introduction Framework

The purpose of this document is to highlight anticipated strengths, challenges, and key questions regarding introduction of the monthly dapivirine vaginal ring in sub-Saharan Africa. This tool is part of the Plan 4 Ring toolkit, a suite of resources and tools designed to support national planning for the introduction and scale-up of the dapivirine ring.

Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery, Supply Chain Management

Presentation
8 August 2022

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women

This press release provides an overview of the new findings from HPTN 084, a trial of the HIV Prevention Trials Network studying injectable cabotegravir for PrEP among cisgender women. The updated results show reductions in HIV incidence were sustained in the 12 months following unblinding and were presented at the AIDS 2022 conference in Montreal.

Research

External Link
4 August 2022

Dual Prevention Pill Desk Review Insights

This desk review by M&C Saatchi collates existing data and insights related to uptake and adherence to HIV prevention, contraceptive, and multi-purpose technology pill products; confirms and identifies gaps in the existing knowledge base; and prompts discussions around key learning questions that need to be addressed to develop a robust and effective marketing and demand…

Demand Creation/Marketing

Document
4 August 2022

Review of Effective Marketing and Demand Creation Strategies in HIV Prevention and Family Planning that May Inform Demand-Side Thinking for the Dual Prevention Pill

This scoping review aims to document effective and sustainable demand creation strategies used in HIV prevention and Family Planning interventions, how they may be adapted for the Dual Prevention Pill (DPP), and explores what could be done differently for the DPP.

Demand Creation/Marketing

Document